Evidence map›Paper›PMID 26044957›Full record

ArticleDisease models & mechanisms2015

MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.

Mohit Sachdeva, Melody J Whitley, Jeffrey K Mito, Yan Ma, Dina C Lev, Diana M Cardona, David G Kirsch

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Disease models & mechanisms, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mohit SachdevaDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC NC27708, USA.
Melody J WhitleyDepartment of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27708, USA.
Jeffrey K MitoDepartment of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27708, USA.
Yan MaDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC NC27708, USA.
Dina C LevDepartment of Cancer Biology, University of Texas, MD Anderson Cancer Center, Houston, TX 77054, USA.
Diana M CardonaDepartment of Pathology, Duke University Medical Center, Durham, NC 27708, USA.
David G KirschDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC NC27708, USA Department of Pharmacology & Cancer Biology, Duke University Medical Center, Durham, NC 27708, USA david.kirsch@duke.edu.
The University of Texas MD Anderson Cancer Center · USDuke University Hospital · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Dissecting Mechanisms of Metastasis Through Comparative Systems GeneticsR01CA138265 · NCI · DUKE UNIVERSITY · PI KIRSCH, DAVID GUY · 2008 to 2012
$2.3M
NCI NIH HHS 5P30-CA14236-38NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA138265
6 · The paper itself

Abstract

MicroRNAs (miRNAs) can regulate tumor cell invasion and metastasis in a tumor-specific manner. We recently demonstrated that global downregulation of miRNAs after deleting dicer can promote development of distant metastases in a mouse model of primary soft tissue sarcoma (STS). In this study, we identified miRNAs that are differentially downregulated in metastatic STS in both human and mouse, and investigated the role of these miRNAs in metastasis. miRNA- TaqMan PCR arrays showed a global downregulation of miRNAs in metastatic human sarcomas. Similar analysis in mouse metastatic sarcomas revealed overlap for several downregulated miRNAs including miR-16, miR-103, miR-146a, miR-223, miR-342 and miR-511. Restoration of these downregulated miRNAs in mouse primary sarcoma cell lines showed that miR-16, but not other downregulated miRNAs, was able to significantly suppress both migration and invasion in vitro, without altering cell proliferation. In addition, orthotopic transplantation of a sarcoma cell line stably expressing miR-16 into the muscle of immunocompromised mice revealed that restoration of miR-16 can significantly decrease lung metastasis in vivo. However, no change in the rate of lung metastasis was observed when miR-16 was deleted in mouse primary sarcomas at sarcoma initiation. Taken together, these results indicate that miR-16 can have metastasis-suppressing properties both in vitro and in vivo. However, the loss-of-function experiments in autochthonous tumors indicate that loss of miR-16 is not sufficient to promote metastasis in vivo.

Indexed as

AnimalsCell Line, TumorCell MovementDisease Models, AnimalDown-RegulationGene DeletionGene Expression Regulation, NeoplasticHumansMice, NudeMicroRNAsNeoplasm InvasivenessNeoplasm MetastasisSarcomaMicroRNAsMirn16 microRNA, mouseGenetic engineeringMetastasisMicroRNAMouse modelsSoft tissue sarcoma

Identifiers

PMID26044957
PMCPMC4527278
OpenAlexW2102280225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.